Shukra Pharmaceuticals operates in the pharmaceutical industry, focusing on the production of injectables. The company’s manufacturing facility is accredited by the World Health Organization (WHO) and other regulatory bodies, highlighting its commitment to quality and compliance.
Business Operations:
The company is involved in the research, production, marketing, and export of a wide range of medical products. Its product portfolio includes macrolides, quinolones, anti-bacterial, anti-fungal, anti-malarial, anti-viral, anti-protozoal, anti-anthelmintic, sedatives, tranquilizers, anti-depressants, anti-manic, anti-emetic, anti-ulcer, beta blockers, diuretics, analgesics, muscle relaxants, anti-tuberculosis, vitamin products, anti-allergics, corticosteroids, hyper and hypoglycemic agents, and antibiotics such as penicillin and cephalosporin.